These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 13896723)

  • 21. Strongyloides stercoralis hyperinfection causing eosinophilic ascites.
    Shukla S; Chauhan R; Wadhwa S; Sehgal S; Singh S
    Diagn Cytopathol; 2015 Sep; 43(9):731-3. PubMed ID: 26097138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Our experiences with modern anthelmintics. II. Effect of dithiazanine on helminths].
    PETRU M; SEIFERT L; VOJTECHOVSKA M
    Cas Lek Cesk; 1962 Jan; 101():85-7. PubMed ID: 14485990
    [No Abstract]   [Full Text] [Related]  

  • 23. Nephrotic syndrome in strongyloidiasis: remission after eradication with anthelmintic agents.
    Wong TY; Szeto CC; Lai FF; Mak CK; Li PK
    Nephron; 1998; 79(3):333-6. PubMed ID: 9678435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effective diagnostic tests and anthelmintic treatment for Strongyloides stercoralis make community control feasible.
    Shield JM; Page W
    P N G Med J; 2008; 51(3-4):105-19. PubMed ID: 21061942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Further clinical trial of a new anthelmintic dilombrin (Pfizer) brand of dithiazanine.
    GLASS J
    J R Nav Med Serv; 1960; 46():75-8. PubMed ID: 13828364
    [No Abstract]   [Full Text] [Related]  

  • 26. A clinical trial of a new anthelmintic--dilombrin (Pfizer) brand of dithiazanine.
    GLASS J
    J R Nav Med Serv; 1959; 45():126-31. PubMed ID: 13828362
    [No Abstract]   [Full Text] [Related]  

  • 27. Strongyloides stercoralis hyperinfection in a patient with AIDS in Uganda successfully treated with ivermectin.
    Orem J; Mayanja B; Okongo M; Morgan D
    Clin Infect Dis; 2003 Jul; 37(1):152-3. PubMed ID: 12830426
    [No Abstract]   [Full Text] [Related]  

  • 28. Strongyloides stercoralis infection in an intestinal transplant recipient.
    Hsu CN; Tseng SH; Chang SW; Chen Y
    Transpl Infect Dis; 2013 Aug; 15(4):E139-43. PubMed ID: 23789974
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Our experiences with modern anthelmintics. I. Dithiazanine, a new anthelmintic with broad spectrum].
    PETRU M; VOSTA J; KOLAR J
    Cas Lek Cesk; 1961 Nov; 100():1424-7. PubMed ID: 14485991
    [No Abstract]   [Full Text] [Related]  

  • 30. [Therapeutic action of dithiazanine in various intestinal parasitoses].
    RUILOBA J; MANCERA R
    Rev Invest Clin; 1959; 11():225-30. PubMed ID: 14440133
    [No Abstract]   [Full Text] [Related]  

  • 31. [Therapeutic test with dithiazanine iodide (netocyd) in infections caused by Hymenolepis nana].
    FERNANDEZ BOUZAS A
    Medicina (Mex); 1959 Nov; 39():496-9. PubMed ID: 13822284
    [No Abstract]   [Full Text] [Related]  

  • 32. Real-time PCR for Strongyloides stercoralis-associated meningitis.
    Nadir E; Grossman T; Ciobotaro P; Attali M; Barkan D; Bardenstein R; Zimhony O
    Diagn Microbiol Infect Dis; 2016 Mar; 84(3):197-9. PubMed ID: 26704620
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Subcutaneous ivermectin as a safe salvage therapy in Strongyloides stercoralis hyperinfection syndrome: a case report.
    Pacanowski J; Santos MD; Roux A; LE Maignan C; Guillot J; Lavarde V; Cornet M
    Am J Trop Med Hyg; 2005 Jul; 73(1):122-4. PubMed ID: 16014846
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment of host immune response against strongyloides stercoralis by human T cell lymphotropic virus type 1 infection.
    Hirata T; Uchima N; Kishimoto K; Zaha O; Kinjo N; Hokama A; Sakugawa H; Kinjo F; Fujita J
    Am J Trop Med Hyg; 2006 Feb; 74(2):246-9. PubMed ID: 16474078
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Diffuse alveolar haemorrhage and severe hypoxemia from Strongyloides stercoralis hyperinfection syndrome.
    El-Sameed YA; Beejay N; Al Maashari R
    Clin Respir J; 2015 Oct; 9(4):489-92. PubMed ID: 24902477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intraduodenal therapy for tenia, hookworm, and strongyloides infection.
    SCHREIBER W
    Gastroenterology; 1959 Sep; 37():346-9. PubMed ID: 14443561
    [No Abstract]   [Full Text] [Related]  

  • 37. Epidemiological and clinical interaction between HTLV-1 and Strongyloides stercoralis.
    Carvalho EM; Da Fonseca Porto A
    Parasite Immunol; 2004; 26(11-12):487-97. PubMed ID: 15771684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Strongyloides stercoralis infection simulating polyarteritis nodosa].
    Masseau A; Hervier B; Leclair F; Grossi O; Mosnier JF; Hamidou M
    Rev Med Interne; 2005 Aug; 26(8):661-3. PubMed ID: 15949873
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [DETECTION OF LARVAE OF STRONGYLOIDES STERCORALIS IN FECES].
    SIFFERTJUNIOR G; RIBEIROEDE S
    Rev Bras Gastroenterol; 1964; 16():33-6. PubMed ID: 14137157
    [No Abstract]   [Full Text] [Related]  

  • 40. Strongyloides stercoralis, the hidden worm. Epidemiological and clinical characteristics of 70 cases diagnosed in the North Metropolitan Area of Barcelona, Spain, 2003-2012.
    Valerio L; Roure S; Fernández-Rivas G; Basile L; Martínez-Cuevas O; Ballesteros ÁL; Ramos X; Sabrià M;
    Trans R Soc Trop Med Hyg; 2013 Aug; 107(8):465-70. PubMed ID: 23783760
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.